[{"_1":2,"_101":-5,"_102":-5},"loaderData",{"_3":4,"_9":10},"root",{"_5":6,"_7":8},"locale","id","isCms",false,"routes/tags/$slug",{"_11":12,"_13":14,"_15":16,"_88":89,"_95":91,"_99":94,"_100":-5},"slug","anlotinib","ads",[],"posts",[17],{"_6":18,"_19":20,"_11":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":33,"_34":35,"_36":37,"_38":39,"_40":41,"_42":43,"_44":20,"_45":46,"_47":48,"_49":50,"_51":20,"_52":53,"_54":55,"_56":57,"_58":59,"_85":86,"_68":87},"019bb769-1d8d-73ba-a2ca-04c40950bcf5","title","Peneliti China temukan pengobatan baru untuk kanker tiroid","peneliti-china-temukan-pengobatan-baru-untuk-kanker-tiroid","main_id","019bb73f-297b-7103-96b7-87ea173dc182","main_name","Iptek","main_slug","iptek-id","date","2021-12-16 17:52:05","author_id","019bb745-b426-73a2-9a49-5ddcb6765ea0","author_name","indowin","full_name","Indonesia Window","author_firstname","Indonesia","author_slug","indonesiawindow","content","Jakarta (Indonesia Window) – Para peneliti China telah menemukan bahwa obat multi-target menunjukkan kemanjuran pada pasien dengan kanker tiroid stadium lanjut lokal, menurut Kantor Berita Xinhua yang dikutip pada Kamis.

Para peneliti dari Pusat Kanker Shanghai Universitas Fudan China melakukan studi klinis yang menunjukkan bahwa anlotinib, obat multitarget, menunjukkan aktivitas antitumor dalam pengobatan neoadjuvant (kemoterapi awal) kanker tiroid stadium lanjut lokal, memungkinkan pasien menerima reseksi radikal.

Pembedahan adalah pengobatan utama untuk kanker tiroid stadium lanjut lokal. Beberapa pasien, bagaimanapun, tidak dapat menjalani operasi reseksi radikal, yang dapat menyebabkan tingkat kesembuhan dan kelangsungan hidup yang rendah, menurut Wang Yu, pemimpin tim peneliti dan profesor di Universitas Fudan.

Studi ini menyelidiki kemanjuran dan keamanan anlotinib selama 2 hingga 6 siklus pada pasien dengan kanker tiroid stadium lanjut lokal dalam pengaturan neoadjuvant. Sebanyak 13 pasien terdaftar dan menerima rata-rata 3,5 siklus pengobatan anlotinib, menurut artikel penelitian yang diterbitkan dalam jurnal Thyroid.

Hasil menunjukkan bahwa anlotinib menunjukkan aktivitas antitumor dalam pengobatan neoadjuvant dengan sembilan pasien mencapai hasil pengobatan yang diharapkan dan menerima reseksi radikal berhasil.

\"Hasil ini menunjukkan bahwa pengobatan neoadjuvant anlotinib merupakan pilihan baru untuk kanker tiroid stadium lanjut secara lokal,\" kata Wang.

Laporan: Redaksi","excerpt","Jakarta (Indonesia Window) – Para peneliti China telah menemukan bahwa obat multi-target menunjukkan kemanjuran pada pasien dengan kanker tiroid stadium lanjut...","seo_kw","seo_title","","seo_description","Penelitian menunjukkan pengobatan neoadjuvant anlotinib merupakan pilihan baru untuk kanker tiroid stadium lanjut secara lokal.","image","2021/12/Tiroid_mountelizabeth.jpg","image_alt","image_caption","Ilustrasi. Para peneliti China telah menemukan bahwa obat multi-target menunjukkan kemanjuran pada pasien dengan kanker tiroid stadium lanjut lokal. (mountelizabeth)","image_url","https://indonesiawindow.sgp1.cdn.digitaloceanspaces.com/2021/12/Tiroid_mountelizabeth.jpg","status","publish","tags",[60,76,81],{"_6":61,"_62":63,"_64":65,"_11":66,"_49":-5,"_67":-5,"_68":69,"_70":69,"_71":72},"019bb744-8462-72b9-8e97-285d2beddce0","old_id",12479,"name","kanker tiroid","kanker-tiroid","description","created_at","2026-01-13T12:11:19.000000Z","updated_at","pivot",{"_73":18,"_74":61,"_68":75,"_70":75},"post_id","tag_id","2026-01-13T12:51:18.000000Z",{"_6":77,"_62":78,"_64":79,"_11":79,"_49":-5,"_67":-5,"_68":69,"_70":69,"_71":80},"019bb744-8466-72c9-8524-3f8ef8b9ae47",12481,"neoadjuvant",{"_73":18,"_74":77,"_68":75,"_70":75},{"_6":82,"_62":83,"_64":12,"_11":12,"_49":-5,"_67":-5,"_68":69,"_70":69,"_71":84},"019bb744-846a-7237-b9ac-31331078c0e8",12483,{"_73":18,"_74":82,"_68":75,"_70":75},"comments",[],"2021-12-16","pagination",{"_90":91,"_92":91,"_93":94,"_95":91,"_96":91,"_97":98},"count",1,"total","perPage",12,"currentPage","totalPages","links",{},"pageSize","error","actionData","errors"]